China (Mainland)
Diamondsupplier 
Terlipressin Acetate CAS No. 14636-12-5 CAS NO.14636-12-5
- Min.Order: 10 Milligram
- Payment Terms: L/C,D/A,D/P,T/T
- Available Specifications:
- Product Details
Keywords
- Terlipressin
- Terlipressin Acetate
- 14636-12-5
Quick Details
- ProName: Terlipressin Acetate CAS No. 14636-12-...
- CasNo: 14636-12-5
- Molecular Formula: C98h138n24o33
- Appearance: white powder
- Application: Terlipressin Acetate
- DeliveryTime: 5 days
- PackAge: Vial or customized
- Port: Shanghai, Beijing, Shenzhen etc.
- ProductionCapacity: 100 Kilogram/Month
- Purity: 99%
- Storage: 2-8℃ sealed and away from light
- Transportation: Ocean and air shipping
- LimitNum: 10 Milligram
- Related Substances: Effective ingredients >99%
- Residue on Ignition: 0.1
- Heavy Metal: 0
- Valid Period: 3 years
Superiority
GMP Manafacturer
High Purity
Competitive Price
Short Delivery Time
Jixianglong has peptide drug production workshop and pilot workshop for personalized cancer neoantigen peptide vaccine which approved by GMP standard. More than 300 sets advanced instruments for production and testing, such as Solid phase synthesizer, Preparative liquid chromatograph, Freeze dryer, High performance liquid chromatograph etc.
Details
Terlipressin Acetate:
CAS No. : 14636-12-5
Peptide Sequence:
Gly-Gly-Gly-Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Lys-Gly-NH2(Disulfide bridge: Cys4-Cys9)
Terlipressin acetate is a vasopressin analog with potent vasoactive properties, which can reduce visceral blood flow and portal pressure and control acute varicose rupture bleeding. Terlipressin acetate can be used to treat hepatorenal syndrome as well.
| Product Name | Terlipressin Acetate |
| CAS NO. | 14636-12-5 |
| Appearance | White Powder |
| Purity | 99% or customized |
| Application | Drug peptides |
| Usage | Terlipressin acetate can reduce visceral blood flow and portal pressure and control acute varicose rupture bleeding, used to treat hepatorenal syndrome as well. |
Company Profile
Founded in 2011, Harbin Jixianglong Biotech Co., Ltd. is a is a professional high-tech company specializing in R&D and production of polypeptide pharmaceuticals. Our advanced industry chain occupied in R&D, approbation and industrialization of peptides API and preparation.
Jixianglong has peptide drug production workshop and pilot workshop for personalized cancer neoantigen peptide vaccine which approved by GMP standard. More than 300 sets advanced instruments for production and testing, such as Solid phase synthesizer, Preparative liquid chromatograph, Freeze dryer, High performance liquid chromatograph etc.
Jixianglong has 10 APIs production approvals, 16 invention patents achieved, including 5 compound patents.